James Boyd Whitmore

Title: James Boyd Whitmore: Innovator in CAR T-cell Therapy

Introduction

James Boyd Whitmore is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cell therapy, particularly in the area of CAR T-cell therapy. His innovative work focuses on improving the safety and efficacy of therapeutic T cell compositions.

Latest Patents

Whitmore holds a patent for "Determining toxicity risk in CAR T-cell therapy." This patent outlines methods, compositions, and articles of manufacture for use in connection with cell therapy involving the administration of therapeutic T cell compositions. The T cell compositions express recombinant receptors, such as chimeric antigen receptors (CARs) or other transgenic receptors. The features of this invention provide various advantages, including a lower risk of toxicity in subjects administered the T cell compositions. He has 1 patent to his name.

Career Highlights

Whitmore is associated with Juno Therapeutics GmbH, where he continues to advance research in cell therapy. His work is pivotal in developing safer therapeutic options for patients undergoing CAR T-cell therapy.

Collaborations

Whitmore has collaborated with notable colleagues, including Brian Christin and Michael Gerard Covington. Their combined expertise contributes to the innovative research and development in the field of cell therapy.

Conclusion

James Boyd Whitmore is a key figure in the advancement of CAR T-cell therapy, with a focus on reducing toxicity risks in treatment. His contributions are vital for the future of cell therapy and patient safety.